Bo Yang
Kunming University of Science and Technology(CN)Ningxia University(CN)Sichuan University(CN)West China Second University Hospital of Sichuan University(CN)Tongde Hospital of Zhejiang Province(CN)Ningxia Academy of Agriculture and Forestry Sciences(CN)Zhejiang Lab(CN)Chengdu Second People's Hospital(CN)ZheJiang Institute For Food and Drug Control(CN)Hunan University of Finance and Economics(CN)Sichuan Academy of Traditional Chinese Medicine(CN)First People's Hospital of Chongqing(CN)Second Affiliated Hospital of Chengdu University of Traditional Chinese(CN)Hangzhou City UniversityZhejiang University(CN)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Pharmaceutical Economics and Policy, Cancer, Lipids, and Metabolism, Anesthesia and Neurotoxicity Research, Chronic Kidney Disease and Diabetes
Most-Cited Works
- → Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder(2015)574 cited
- → Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia(2002)386 cited
- → Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies(2001)312 cited
- → Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein(2003)126 cited
- → ω-6 Polyunsaturated fatty acids (linoleic acid) activate both autophagy and antioxidation in a synergistic feedback loop via TOR-dependent and TOR-independent signaling pathways(2020)119 cited
- → Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin